...In 1960 a pediatric surgeon and cell biologist named Judah Folkman came up with a novel approach to cancer. It took him...drug in the new class of cancer compounds that Dr. Judah Folkman's research has launched. The Celgene Corp. will...
...adds to a growing list of proteins known to block cancer by preventing blood vessel formation. Researchers led by Judah Folkman and Michael S. O'Reilly at Boston's Children's Hospital and Harvard Medical School found that antithrombin...
...senior investigator at the National Cancer Institute, said in today's Boston Globe. The drug, discovered by Dr. Judah Folkman and his colleagues, is undergoing three separate trials with a starting total of 45 patients. The Cancer Institute...
...and made them disappear altogether. The drugs also appear to prevent the spread of tumors. Their innovator, Dr. Judah Folkman, a Harvard professor and researcher at Boston's Children's Hospital, called the combination of proteins "very...
...in a manner completely differently than other treatments. That theory was pioneered by Harvard University's Dr. Judah Folkman, who made front-page news in 1998 with reports that his anti-angiogenesis drugs had cured mice of cancer. But...
...see that happening. I've been hearing that for too long now. (But) I do think there is something there." Dr. Judah Folkman of Harvard University is using two compounds called angiostatin and endostatin, which are potent anti-angiogenesis...
...vessels that nourish tumors. Last year, in one of the most celebrated developments in angiogenesis research, Dr. Judah Folkman of Harvard University reported that two proteins, angiostatin and endostatin, caused tumors in rats to shrink or...
...against both heart disease and cancer, the two most important diseases of the industrialized world. A team led by Dr. Judah Folkman of Harvard Medical School and Children's Hospital in Boston reported the development in today's issue of the American...
...nutrients -- searching for possible ways to shut off that blood vessel growth. The research intensified after Dr. Judah Folkman of Children's Hospital in Boston showed that a compound he calls angiostatin could stop tumor growth in mice by blocking...
...vessels came from optimistic coverage of the development of the drugs endostatin and angiostatin by Harvard's Dr. Judah Folkman, the field's pioneer. Endostatin is in early testing at three hospitals, and participating doctors have been silent...
The Augusta Chronicle ©2011. All Rights Reserved.